Correction: MiR-132 Enhances Proliferation and Migration of HaCaT Cells by Targeting TIMP3.

Lina Jiang,Yizhou Jiang,Xiaohui Ji,Jiangtao Li,Xiaomei Zhai

DOI: https://doi.org/10.1039/d0ra90075c

IF: 4.036

2020-01-01

RSC Advances

Abstract:Correction for ‘MiR-132 enhances proliferation and migration of HaCaT cells by targeting TIMP3’ by Lina Jiang et al., RSC Adv., 2019, 9, 21125–21133, DOI: 10.1039/C8RA10552A.

What problem does this paper attempt to address?

Retracted Article: MiR-132 Enhances Proliferation and Migration of HaCaT Cells by Targeting TIMP3

Lina Jiang,Yizhou Jiang,Xiaohui Ji,Jiangtao Li,Ximei Zhai

DOI: https://doi.org/10.1039/c8ra10552a

IF: 4.036

2019-01-01

RSC Advances

Abstract:MicroRNAs (miRNAs) are involved in multiple skin pathologies, including wound healing. Here, we explored the detailed role and molecular mechanism of miR-132 on HaCaT cells proliferation and migration. qRT-PCR assay was used to assess miR-132 expression and Western blot analysis was performed to detect inhibitor of matrix metalloproteinase-3 (TIMP3) level in HaCaT cells and normal human epidermal keratinocytes (NHEK) under transforming growth factor β1 (TGF-β1) treatment. Dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay were employed to confirm the endogenous interaction between miR-132 and TIMP3. Cell proliferation ability was determined by MTT assay and the migration capacity was evaluated by transwell assay. TGF-β1 treatment resulted in a increase of miR-132 expression and a decrease of TIMP3 level in HaCaT cells and NHEK cells. The proliferation and migration abilities of TGF-β1-treated HaCaT cells were promoted by miR-132 upregulation, while them were inhibited by TIMP3 overexpression. Moreover, TIMP3 was a direct target of miR-132. MiR-132-mediated pro-proliferation and pro-migration effects were antagonized by TIMP3 in HaCaT cells under TGF-β1 treatment. Our data supported that miR-132 promoted the proliferation and migration of HaCaT cells at least partly by targeting TIMP3, highlighting miR-132 as a potential therapeutic strategy of wound healing.
Retracted: Mir-132 Enhances Proliferation And Migration Of Hacat Cells By Targeting Timp3 (Retracted Article. See Vol. 11, Pg. 5002, 2021)

Lina Jiang,Yizhou Jiang,Xiaohui Ji,Jiangtao Li,Ximei Zhai

DOI: https://doi.org/10.1039/c8ra10552a

IF: 4.036

2019-01-01

RSC Advances

Abstract:MicroRNAs (miRNAs) are involved in multiple skin pathologies, including wound healing. Here, we explored the detailed role and molecular mechanism of miR-132 on HaCaT cells proliferation and migration. qRT-PCR assay was used to assess miR-132 expression and Western blot analysis was performed to detect inhibitor of matrix metalloproteinase-3 (TIMP3) level in HaCaT cells and normal human epidermal keratinocytes (NHEK) under transforming growth factor beta 1 (TGF-beta 1) treatment. Dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay were employed to confirm the endogenous interaction between miR-132 and TIMP3. Cell proliferation ability was determined by MTT assay and the migration capacity was evaluated by transwell assay. TGF-beta 1 treatment resulted in a increase of miR-132 expression and a decrease of TIMP3 level in HaCaT cells and NHEK cells. The proliferation and migration abilities of TGF-beta 1-treated HaCaT cells were promoted by miR-132 upregulation, while them were inhibited by TIMP3 overexpression. Moreover, TIMP3 was a direct target of miR-132. MiR-132-mediated pro-proliferation and pro-migration effects were antagonized by TIMP3 in HaCaT cells under TGF-beta 1 treatment. Our data supported that miR-132 promoted the proliferation and migration of HaCaT cells at least partly by targeting TIMP3, highlighting miR-132 as a potential therapeutic strategy of wound healing.
Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou,Mahboubeh Yazdanifar,Lopamudra Das Roy,Lynsey M. Whilding,Artemis Gavrill,John Maher,Pinku Mukherjee

DOI: https://doi.org/10.3389/fimmu.2020.628776

IF: 7.3

2020-12-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

immunology
Erratum: miR-181a, delivered by hypoxic PTC-secreted exosomes, inhibits DACT2 by downregulating MLL3, leading to YAP-VEGF-mediated angiogenesis

Yingxue Wang,Aiying Cen,Yuxian Yang,Huilin Ye,Jiaying Li,Shiliang Liu,Lei Zhao

DOI: https://doi.org/10.1016/j.omtn.2024.102239

2024-06-07

Abstract:[This corrects the article DOI: 10.1016/j.omtn.2021.02.027.].
The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4: Erratum

Liu Yang,Yang Guo,Xin Liu,Tongtong Wang,Xiangmin Tong,Kefeng Lei,Jiahui Wang,Dongsheng Huang,Qiuran Xu

DOI: https://doi.org/10.7150/jca.76866

IF: 3.9

2022-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.25569.].

oncology
Correction: MiR-HCC2 Up-regulates BAMBI and ELMO1 Expression to Facilitate the Proliferation and EMT of Hepatocellular Carcinoma Cells

Jianying Yi,Yajie Fan,Le Zhang,Hong Wang,Ting Mu,Hong Xie,Huijie Gao,Min Liu,Shengping Li,Hua Tang

DOI: https://doi.org/10.7150/jca.66366

IF: 3.9

2021-01-01

Journal of Cancer

Abstract:[This corrects the article DOI: 10.7150/jca.30858.].

oncology
[Corrigendum] MicroRNA‐378 enhances migration and invasion in cervical cancer by directly targeting autophagy‐related protein 12

Dongmei Tan,Chao Zhou,Sai Han,Xuetao Hou,Shufang Kang,Youzhong Zhang

DOI: https://doi.org/10.3892/mmr.2024.13366

IF: 3.423

2024-10-18

Molecular Medicine Reports

Abstract:Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, for the cell migration and invasion assay experiments shown in Fig. 2 on p. 6322, the 'HeLa/miR‐378 inhibitor' panels in Fig. 2B and C appeared to contain overlapping sections of data, such that these data panels were apparently derived from the same original source to show the results of purportedly different experiments. The authors have re‐examined their original data, and realize that Fig. 2C was inadvertently assembled incorrectly. The revised version of Fig. 2, now containing the correct data for the 'HeLa/miR‐378 inhibitor' experiment in Fig. 2C, is shown on the next page. Note that this error did not adversely affect either the results or the overall conclusions reported in this study. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of Molecular Medicine Reports for allowing them the opportunity to publish this. They also wish to apologize to the readership of the Journal for any inconvenience caused. [Molecular Medicine Reports 17: 6319‐6326, 2018; DOI: 10.3892/mmr.2018.8645]

oncology,medicine, research & experimental
[Corrigendum] miR‐26a inhibits ovarian cancer cell proliferation, migration and invasion by targeting TCF12

Sainan Gao,Tingting Bian,Min Su,Yifei Liu,Yuquan Zhang

DOI: https://doi.org/10.3892/or.2024.8715

2024-02-16

Oncology Reports

Abstract:Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, on p. 372, the data panels shown to represent the 'NC' and 'Untreated' data panels in Fig. 5A for the Transwell cell invasion assay experiments were apparently overlapping, suggesting that these data had been derived from the same original source, even though they were meant to have shown the results from differently performed experiments. The authors were able to re‐examine their original data files, and realize that this figure had been assembled incorrectly; the revised version of Fig. 5, now featuring the correct data panel for the 'Untreated' experiment, is shown on the next page. Note that the revisions made to this figure do not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum, and apologize to the readership for any inconvenience caused. [Oncology Reports 43: 368‐374, 2020; DOI: 10.3892/or.2019.7417]

oncology
[Corrigendum] MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma

Liwen Zhao,Jing Quan,Zuwei Li,Xiang Pan,Jingyao Wang,Jinling Xu,Weijie Xu,Xin Guan,Hang Li,Shangqi Yang,Yaoting Gui,Yun Chen,Yongqing Lai

DOI: https://doi.org/10.3892/ijmm.2024.5377

Abstract:Following the publication of the above article, an interested reader drew to the attention of the Editorial Office that, in Fig. 3A on p. 530, two pairs of data panels were overlapping, such that certain of the panels appeared to have been derived from the same original sources where the results from differently performed experiments were intended to have been portrayed. The authors have examined their original data, and realize that errors associated with data handling/labelling during the preparation of the representative images in Fig. 3A had occurred. The revised version of Fig. 3, showing the correct data for the 'NC/ACHN/Invasion and Migration' data panels, the 'Inhibitor NC/786‑O' panel and the 'Inhibitor NC/ACHN/Invasion' panel, is shown on the next page. The authors can confirm that the errors associated with this figure did not have any significant impact on either the results or the conclusions reported in this study, and all the authors agree with the publication of this Corrigendum. The authors are grateful to the Editor of International Journal of Molecular Medicine for giving them the opportunity to publish this Corrigendum; furthermore, they apologize to the readership of the Journal for any inconvenience caused. [International Journal of Molecular Medicine 43: 525‑534, 2019; DOI: 10.3892/ijmm.2018.3931].
[Corrigendum] miR‐27a‐3p regulates the inhibitory influence of endothelin 3 on the tumorigenesis of papillary thyroid cancer cells

Hongxin Chen,Binlin Cai,Kun Liu,Qingquan Hua

DOI: https://doi.org/10.3892/mmr.2021.12105

IF: 3.423

2021-04-19

Molecular Medicine Reports

Abstract:Following the publication of the above article, the authors have realized that Figs. 4 and 7 contained data panels that had been erroneously assembled in these figures. These errors arose as a consequence of miscommunication among several of the authors, and changes in personnel throughout the course of the project. The revised versions of Figs. 4 and 7 are shown on the next page. Note that the replacement of the data shown also merits some changes being made to the descriptions in the Results section for the relevant figures (changed text is highlighted in bold). In the 'EDN3 overexpression in PTC cells impairs cell migration and invasion' subsection of the Results section in the right‑hand column of p. 6, the second sentence should now read as follows: 'To detect the invasiveness of TPC‑1 and GLAG‑66 cells, transwell assay was performed, and the results of the transwell assay indicated that the number of cells invaded decreased by about 40% after transfecting with EDN3‑OE (Fig. 4C and D)'. Secondly, the last sentence on p. 11 should be rephrased to the following: 'The transwell assay results revealed that the invasion was enhanced in the miR‑27a‑3p mimic group and the invasion was suppressed in cells of the EDN3‑OE group, compared with the control group and the co‑transfection group (Fig. 7C and D)'. All the authors approve of the publication of this corrigendum, and the authors are grateful to the Editor of Molecular Medicine Reports for granting them the opportunity to publish this. The authors regret that these errors were included in the paper, and also apologize to the readership for any inconvenience caused. [the original article was published in Molecular Medicine Reports 23: 243, 2021; DOI: 10.3892/mmr.2021.11882].

oncology,medicine, research & experimental
Correction To: MiR-139-5p Inhibits Migration and Invasion of Colorectal Cancer by Downregulating AMFR and NOTCH1

Mingxu Song,Yuan Yin,Jiwei Zhang,Binbin Zhang,Zehua Bian,Chao Quan,Leyuan Zhou,Yaling Hu,Qifeng Wang,Shujuan Ni,Bojian Fei,Weili Wang,Xiang Du,Hua Dong,Zhaohui Huang

DOI: https://doi.org/10.1007/s13238-021-00826-x

2021-01-01

Protein & Cell

Abstract:In the original publication the display of Fig. 1 is incorrect. The correct figure is available in this correction.
[Corrigendum] miR‐135 regulated breast cancer proliferation and epithelial‐mesenchymal transition acts by the Wnt/β‐catenin signaling pathway

Daqiong Jiang,Bo Zhou,Yan Xiong,Hongbing Cai

DOI: https://doi.org/10.3892/ijmm.2022.5161

IF: 5.314

2022-06-20

International Journal of Molecular Medicine

Abstract:After the publication of the above article, an interested reader drew to the authors' attention that, in Fig. 2A on p. 1626, the data panels showing the results for the 'Bright/Blank control' and 'Bright/mi‑135 inhibitors' experiments appeared to be identical; furthermore, in Fig. 8 on p. 1632, Figs. 8B and D appeared to contain identical data, even though the contrast settings for the two sets of panels were a little different. The authors have re‑examined their original data, and regret that Figs. 2 and 8 were inadvertently both assembled incorrectly, as identified by the external reader. However, the authors retained their original data, and were able to reassemble both these figures correctly. The revised versions of Figs. 2 and 8 are shown on the next two pages, now including the correct data for the 'Bright/Blank control' experiment in Fig. 2A and the correct immunofluorescence data in Fig. 8B. Note that the revised data shown for these figures do not affect the overall conclusions reported in the paper. The authors express their gratitude to the Editor of International Journal of Molecular Medicine for allowing them the opportunity to publish this corrigendum, and apologize to the readership for any inconvenience caused. [Journal of Molecular Medicine 43: 1623‑1634, 2019; DOI: 10.3892/ijmm.2019.4081].

medicine, research & experimental
[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer

Hong Tan,Qingnan He,Guanhui Gong,Yixuan Wang,Juanni Li,Junpu Wang,Ding Zhu,Xiaoying Wu

DOI: https://doi.org/10.3892/ijo.2024.5698

Abstract:Following the publication of the above article, an interested reader drew to the authors' attention that certain of the Transwell migration and invasion assay data panels shown in Figs. 3E and G and 7E and G on p. 1754 and 1757 respectively contained overlapping data panels, both within Fig. 3 and between Figs. 3 and 7, such that data which were intended to represent the results of differently performed experiments had apparently been derived from the same original sources. Specifically, the 'con' and 'pre-con' data panels in Fig. 3 were overlapping, as were the 'pre-con' and 'pcDNA.1-ROR1' panels comparing Fig. 3 with Fig. 7, and the Editorial Office subsequently pointed out to the authors that the 'con' and 'pre-con' data panels in Fig. 3E also contained an overlapping edge. After having examined their original data, the authors realized that these figures were inadvertently assembled incorrectly. The corrected versions of Figs. 3 and 7 are shown on the next page, now showing the correct data for the 'con' experiment in Fig. 3E, the 'pre-con' experiment in Fig. 3G, and the 'pcDNA.1-ROR1' panel in Fig. 7G. 'The authors are grateful to the Editor of International Journal of Oncology for granting them the opportunity to publish this corrigendum, and all the authors agree with its publication; furthermore, they apologize to the readership of the journal for any inconvenience caused. [International Journal of Oncology 48: 181-190, 2016; DOI: 10.3892/ijo.2015.3241].
miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer: Erratum

Xiaomin Liu,Xianyi Wang,Binshu Chai,Zong Wu,Zhenyu Gu,Heng Zou,Hui Zhang,Yanli Li,Qiangling Sun,Wentao Fang,Zhongliang Ma

DOI: https://doi.org/10.7150/ijbs.86344

2023-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.70312.].
[Corrigendum] Roles of the H19/microRNA‑675 Axis in the Proliferation and Epithelial‑mesenchymal Transition of Human Cutaneous Squamous Cell Carcinoma Cells

Wenqing Zhang,Kaili Zhou,Xue Zhang,Chenglong Wu,Dan Deng,Zhirong Yao

DOI: https://doi.org/10.3892/or.2021.7990

2023-01-01

Oncology Reports

Abstract:Following the publication of the above paper, a concerned reader drew to the authors' attention that, in Fig. 4C on p. 8, the 'Invasion, miR‑675‑inhibitor' data panel appeared to contain an overlapping section with the 'Invasion, mi‑R675‑inhibitor + pcDNA3.1‑H19' data panel for the SCL1 cell line, such that the data were likely to have been derived from the same original source, even though they were intended to show the results from differently performed experiments. After having examined the original data, the authors also realized that the 'Inhibitor‑NC' and 'miR‑675‑inhibitor' data panels showing the migration assay experiments for the A431 cell line in the same figure part had also inadvertently been derived from the same original source. After having been granted permission from the Editor of Oncology Reports to repeat the experiments shown in Fig. 4C, the revised version of Fig. 4, incorporating the new data for Fig. 4C, is shown on the next page. Note that these errors did not affect the overall conclusions reported in the study, and the repeated experiment yielded similar results to those obtained originally. The authors are grateful to the Editor for allowing them the opportunity to publish this corrigendum, and all the authors agree with the publication of this; furthermore, they apologize for any inconvenience caused to the readership of the Journal. [Oncology Reports 45: 39, 2021; DOI: 10.3892/or.2021.7990].
[Corrigendum] miR‑1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer.

Yuqing Pei,Kexin Li,Xiaoying Lou,Yue Wu,Xin Dong,Wenpeng Wang,Ning Li,Donghong Zhang,Wei Cui

DOI: https://doi.org/10.3892/or.2023.8533

2023-01-01

Oncology Reports

Abstract:Following the publication of the above article, a concerned reader drew to the authors' attention that the data shown for the 'CAOV3/NC mimics' experiment in Fig. 2D on p. 443 appeared to be the same as that shown for the 'TUG1‑sh+miR‑1299 inhibitors' experiment in Fig. 4H on p. 444. The authors have examined their original data, and realize that the same data was inadvertently included in the two figures. Consequently, the corrected version of Fig. 2, featuring the correct data for the 'CAOV3/NC mimics' experiment in Fig. 2D, is shown opposite. The overall conclusions of this study were not affected by this error. All the authors agree to the publication of this corrigendum, and are grateful to the Editor of for allowing them the opportunity to publish this; furthermore, they apologize to the readership for any inconvenience caused. [Oncology Reports 44: 438-448, 2020; DOI: 10.3892/or.2020.7623].
Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis

Xiaoqiang Liu,Zhengtao Zhou,Yibing Wang,Ke Zhu,Wen Deng,Yulei Li,Xiaochen Zhou,Luyao Chen,Yu Li,An Xie,Tao Zeng,Gongxian Wang,Bin Fu

DOI: https://doi.org/10.3389/fonc.2020.01735

IF: 4.7

2020-09-04

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00589.].

oncology
Corrigendum to “miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1”

Hao Wang,Chenyang Li,Yunxia Wang,Nan Li,Yanli Qin,Yesheng Wang

DOI: https://doi.org/10.1155/2021/9868462

2021-12-24

Analytical Cellular Pathology

Abstract:[This corrects the article DOI: 10.1155/2021/7407086.].

oncology,pathology,cell biology
Correction To: Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells Via the Inhibition of STAT3 Signaling and Down-Regulation of Inflammatory Cytokine Expressions

Wei Yan,Bing Tu,Yun-Yun Liu,Ting-Yu Wang,Han Qiao,Zan-Jing Zhai,Hao-Wei Li,Ting-Ting Tang

DOI: https://doi.org/10.1038/s41413-019-0052-0

IF: 12.7

2019-01-01

Bone Research

Abstract:[This corrects the article DOI: 10.4248/BR201304007.].
Erratum to erratum to miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression

Editorial Office

DOI: https://doi.org/10.21037/tcr-2024-2

2024-09-02

Translational Cancer Research

Abstract:Editorial Office Translational Cancer Research Submitted Nov 20, 2023. Accepted for publication Jun 12, 2024. Published online Aug 27, 2024. doi: 10.21037/tcr-2024-2 Erratum to: Transl Cancer Res 2023;12:1372-5. In the May 2023 issue of Translational Cancer Research , the paper titled "Erratum to miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression" (Transl Cancer Res 2023;12(5):1372-1375. doi: 10.21037/tcr-23-674) (1), was published for correction of Figure 1C and Figure 5C in the article (2) published earlier. However, there are still some errors found in the aforementioned Figures 1C , 5C as well as in Figure 4C , while the figure legends remain intact. The Figure 1C should be corrected as: The Figure 4C should be corrected as: The Figure 5C should be corrected as: The authors confirmed that these corrections do not change the description or original conclusions of the paper and sincerely apologize for any inconvenience caused by these mistakes. Click here to view the updated version of the article. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.

oncology

Correction: MiR-132 Enhances Proliferation and Migration of HaCaT Cells by Targeting TIMP3.

Retracted Article: MiR-132 Enhances Proliferation and Migration of HaCaT Cells by Targeting TIMP3

Retracted: Mir-132 Enhances Proliferation And Migration Of Hacat Cells By Targeting Timp3 (Retracted Article. See Vol. 11, Pg. 5002, 2021)

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Erratum: miR-181a, delivered by hypoxic PTC-secreted exosomes, inhibits DACT2 by downregulating MLL3, leading to YAP-VEGF-mediated angiogenesis

The tumor suppressive miR-302c-3p inhibits migration and invasion of hepatocellular carcinoma cells by targeting TRAF4: Erratum

Correction: MiR-HCC2 Up-regulates BAMBI and ELMO1 Expression to Facilitate the Proliferation and EMT of Hepatocellular Carcinoma Cells

[Corrigendum] MicroRNA‐378 enhances migration and invasion in cervical cancer by directly targeting autophagy‐related protein 12

[Corrigendum] miR‐26a inhibits ovarian cancer cell proliferation, migration and invasion by targeting TCF12

[Corrigendum] MicroRNA‑222‑3p promotes tumor cell migration and invasion and inhibits apoptosis, and is correlated with an unfavorable prognosis of patients with renal cell carcinoma

[Corrigendum] miR‐27a‐3p regulates the inhibitory influence of endothelin 3 on the tumorigenesis of papillary thyroid cancer cells

Correction To: MiR-139-5p Inhibits Migration and Invasion of Colorectal Cancer by Downregulating AMFR and NOTCH1

[Corrigendum] miR‐135 regulated breast cancer proliferation and epithelial‐mesenchymal transition acts by the Wnt/β‐catenin signaling pathway

[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer

miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer: Erratum

[Corrigendum] Roles of the H19/microRNA‑675 Axis in the Proliferation and Epithelial‑mesenchymal Transition of Human Cutaneous Squamous Cell Carcinoma Cells

[Corrigendum] miR‑1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer.

Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis

Corrigendum to “miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1”

Correction To: Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells Via the Inhibition of STAT3 Signaling and Down-Regulation of Inflammatory Cytokine Expressions

Erratum to erratum to miR-3614-3p suppresses cell aggressiveness of human breast cancer by targeting AKT3 and HDAC1 expression